To market generic version of omeprazole and sodium bicarbonate
Granules India announced that its subsidiary, Granules USA has entered into an agreement with Par Pharmaceutical Inc., a subsidiary of Endo International plc, to market the/a generic version of OTC omeprazole and sodium bicarbonate in North America following approval by the USFDA's which is currently expected in July 2016. Par Pharmaceutical's omeprazole and sodium bicarbonate is the generic equivalent of Merk/MSD Consumer Care, Inc's Zegerid OTC.Powered by Capital Market - Live News
